Clinical Trials in Massachusetts

Showing 5781-5800 of 13,570 trials

COMPLETED13 miles

Symptom Burden in Patients Treated With Ocrelizumab for Multiple Sclerosis

NCT04855617

This study is designed to determine whether symptom burden differs by time to infusion.

Multiple Sclerosis

NYU Langone Health122 participantsStarted Oct 2020

Wellesley, Massachusetts, United States • New York, New York, United States

COMPLETEDPhase 320 miles

Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines

NCT04225260

This is a phase 3, multicenter, open-label study to evaluate the safety of QM1114-DP for the long term treatment of moderate to severe Glabellar (Frown) Lines (GL) and Lateral Canthal Lines (Crow's Feet and LCL).

Glabellar LinesLateral Canthal Lines

Galderma R&D902 participantsStarted Jan 2020

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Fremont, California, United States +27 more locations

Symptom Burden in Patients Treated With Ocrelizumab for Multiple Sclerosis

Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines

Find Trials by Condition in Massachusetts

Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma

High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed

Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression

A Long Term Safety Study of BCX7353 in Hereditary Angioedema

(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC

Implementation of Women's Health Patient Aligned Care Teams

A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection

Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism

The Navigator Trial

Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer

Mucin Levels in Dry Eye and Normal Populations

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

Study of MT-5111 in HER2-positive Solid Tumors